Skip to search formSkip to main contentSkip to account menu

formoterol

Known as: Formoterol [Chemical/Ingredient], Eformoterol, 2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide 
A long-acting beta-adrenergic receptor agonist with bronchodilator activity. Formoterol selectively binds to beta-2 adrenergic receptors in bronchial… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
ABSTRACT Objective: To assess the bronchodilator efficacy, safety and tolerability of indacaterol, a novel, once-daily inhaled β2… 
Highly Cited
1999
Highly Cited
1999
The present study was designed to observe the effects of 8 wk of treatment with formoterol (Foradil) 24 microgram, budesonide 400… 
1999
1999
Short-acting beta2-agonists provide greater protection against bronchoconstriction induced by adenosine 5'-monophosphate (AMP… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND--There is controversy as to the role of long acting beta 2 agonists such as eformoterol and, in particular, whether… 
Highly Cited
1992
Highly Cited
1992
1 The effects of the β2‐adrenoceptor agonists, salbutamol and formoterol, on the increase of microvascular permeability induced… 
Highly Cited
1991
Highly Cited
1991
In a randomized, double-blind, crossover cumulative study, the individual maximal bronchodilator dosages for formoterol (F) and…